A stable Escherichia coli-mycobacteria shuttle vector 'pSO246' in Mycobacterium bovis BCG

FEMS Microbiology Letters

Volumn 135, Issue 2-3, 1996, Pages 237-243

  Matsumoto, Sohkichi ^a   Tamaki, Mikio ^b   Yukitake, Hideharu ^a   Matsuo, Takemitu ^a   Naito, Mariko ^a   Teraoka, Hiroshi ^b   Yamada, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

Author keywords

Mycobacteria; pAL5000; Plasmid vector

Indexed keywords

BCG VACCINE;

ARTICLE; BACTERIAL GENE; BACTERIUM MUTANT; ESCHERICHIA COLI; MYCOBACTERIUM; NONHUMAN; PLASMID; PRIORITY JOURNAL;

EID: 0030040274     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1097(95)00457-2     Document Type: Article

References (27)

1. Labidi A., David H.L. and Roulland D.D. (1985) Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann Inst. Pasteur Microbiol. 136, 209-215.
2. Snapper S.B., Melton R.E., Mustafa S., Kieser T. and Jacobs W.J. (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4, 1911-1919.
3. Lugosi L., Jacobs W.J. and Bloom B.R. (1989) Genetic transformation of BCG. Tubercle 70, 159-170.
4. Matsuo K., Yamaguchi R., Yamazaki A., Tasaka H., Terasaka K., Totsuka M., Kobayashi K., Yukitake H. and Yamada T. (1990) Establishment of a foreign antigen secretion system in mycobacteria. Infect. Immun. 58, 4049-4054.
5. Hinshelwood S. and Stoker N.G. (1992) An Escherichia coli-Mycobacterium shuttle cosmid vector, pMSC1. Gene 110, 115-118.
6. Zainuddin Z.F., Kunze Z.M. and Dale J.W. (1989) Transformation of Mycobacterium smegmatis with Escherichia coli plasmids carrying a selectable resistance marker. Mol. Microbiol. 3, 29-34.
7. Messerotti L.J., Radford A.J. and Hodgson A.L. (1990) Nucleotide sequence of the replication region from the Mycobacterium - Escherichia coli shuttle vector pEP2. Gene 96, 147-148.
8. Radford A.J. and Hodgson A.L. (1991) Construction and characterization of a Mycobacterium-Escherichia coli shuttle vector. Plasmid 25, 149-153.
9. Goto Y., Taniguchi H., Udou T., Mizuguchi Y. and Tokunaga T. (1991) Development of a new host vector system in mycobacteria. FEMS Microbiol. Lett. 67, 277-282.
10. David M., Lubinsky M.S., Ben Z.A., Ulitzur S., Kuhn J. and Suissa M. (1992) A stable Escherichia coli-Mycobacterium smegmatis plasmid shuttle vector containing the mycobacteriophage D29 origin. Plasmid 28, 267-271.
11. Qin M., Taniguchi H. and Mizuguchi Y. (1994) Analysis of the replication region of a mycobacterial plasmid, pMSC262. J. Bacteriol. 176, 419-425.
12. Berg D.E., Davies J., Allet B. and Rochaix J.D. (1975) Transposition of R factor genes to bacteriophage lambda. Proc. Natl. Acad. Sci. USA 72, 3628-3632.
13. Beck E., Ludwig G., Auerswald E.A., Reiss B. and Schaller H. (1982) Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 19, 327-336.
14. Villar C.A. and Benitez J. (1992) Functional analysis of pAL5000 plasmid in Mycobacterium fortuitum. Plasmid 28, 166-169.
15. Matsumoto S., Matsuo T., Ohara N., Hotokezaka H., Naito M., Minami J. and Yamada T. (1995) Cloning and sequencing of a unique antigen MPT70 from Mycobacterium tuberculosis H37Rv and expression in BCG using E. colimycobacteria shuttle vector. Scand. J. Immunol. 41, 281-287.
16. Matsuo K., Yamaguchi R., Yamazaki A., Tasaka H., Terasaka K. and Yamada T. (1990) Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii. Infect. Immun. 58, 550-556.
17. O'Farrell P.H. (1975). High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021.
18. Stover C.K., de la Cruz, Vf, Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., Bansal G.P., Young J.F., Lee M.H., Hatfull G.F., Snapper S.B., Barletta R.G., Jacobs Jr W.R., and Bloom B.R. (1991) New use of BCG for recombinant vaccines. Nature 351, 456-460.
19. Aldovini A. and Young R.A. (1991) Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature 351, 479-482.
20. Haeseleer F., Pollet J.F., Haumont M., Bollen A. and Jacobs P. (1993) Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria. Mol. Biochem. Parasitol. 57, 117-126.
21. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., Koenig S., Young D.B., Sadziene A. and Barbour A.G. (1993) Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178, 197-209.
22. Yasutomi Y., Koenig S., Haun S.S., Stover C.K., Jackson R.K., Conard P., Conley A.J., Emini E.A., Fuerst T.R. and Letvin N.L. (1993) Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys. J. Immunol. 150, 3101-3107.
23. Lagranderie M., Murray A., Gicquel B., Leclerc C. and Gheorghiu M. (1993) Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine 11, 1283-1290.
24. O'Donnell M.A., Aldovini A., Duda R.B., Yang H., Szilvasi A., Young R.A. and DeWolf W.C. (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect. Immun. 62, 2508-2514.
25. Langermann S., Palaszynski S., Sadziene A., Stover C.K. and Koenig S. (1994) Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552-555.
26. Langermann S., Palaszynski S.R., Burlein J.E., Koenig S., Hanson M.S., Briles D.E. and Stover C.K. (1994) Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180, 2277-2286.
27. Kameoka M., Nishino Y., Matsuo K., Ohara N., Kimura T., Yamazaki A., Yamada T. and Ikuta K. (1994) Cytotoxic T lymphocyte response in mice induced by a recombinant BCG vaccination which produces an extracellular alpha antigen that fused with the human immunodeficiency virus type 1 envelope immunodominant domain in the V3 loop. Vaccine 12, 153-158.